How Long Can a Nephrostomy Tube Remain in the Kidney?

A nephrostomy tube can remain in the kidney indefinitely, as long as it is routinely exchanged for a fresh one before the old tube becomes blocked or damaged. In practice, most institutions schedule replacement somewhere between every 60 and 90 days, though some patients need exchanges far more often. The tube itself is not a permanent implant in the way a joint replacement is; it is a drain that slowly deteriorates inside the body and must be swapped out on a recurring basis. How often that swap needs to happen depends on the tube material, the underlying condition, and the patient’s own body chemistry.

Why the Tube Cannot Simply Stay Forever

Any device sitting inside the urinary tract starts collecting a mineral crust almost immediately. Urine is full of dissolved salts, and those salts precipitate onto foreign surfaces the way limescale builds up inside a kettle. Bacteria compound the problem by forming a sticky layer called a biofilm on the tube’s surface. That biofilm traps even more mineral deposits and creates a sheltered environment where infections can take hold. Together, encrustation and biofilm are the main reasons a nephrostomy tube has a limited lifespan inside the body. Infection and encrustation remain the primary factors limiting how long any urinary tract device can stay in place.¹

On top of mineral buildup, the tube material itself breaks down. One study examining polyurethane nephrostomy catheters found that after just two months of use, more than half showed visible discoloration and surface damage.² The degraded surfaces had calcium and other ions deposited on them. Interestingly, the damage did not correlate with urine pH, which means you cannot simply predict tube lifespan by testing how acidic or alkaline a patient’s urine is. The deterioration appears to be driven by a combination of body fluids, temperature, and time rather than any single measurable factor.

Typical Exchange Schedules

Different hospitals and clinical guidelines land on slightly different intervals. One large modeling study focused on patients with cancer-related urinary obstruction concluded that the optimal routine exchange interval was roughly 60 days.³ Other institutions use a 90-day cycle.⁴ The difference usually comes down to the patient population and local experience with complication rates. Patients with malignant obstruction, for instance, often have urine that is more prone to encrustation because of the tumor itself, chemotherapy effects, or reduced fluid intake, which can favor a shorter interval.

What matters as much as the interval itself is whether patients actually show up for their scheduled exchanges. The same modeling study found that whether patients comply with their exchange appointments has a bigger impact on outcomes and costs than the exact number of days between swaps. When a tube is left in too long and blocks, the resulting emergency visit for infection or obstruction can cost roughly ten times more than a routine exchange would have.³ Missing an appointment is far riskier than the difference between a 60-day and a 90-day schedule.

How Tube Material Affects Longevity

The two most common tube materials are silicone and polyurethane, and each has trade-offs that influence how long the tube lasts before it needs to come out. A comparative study of the two materials in patients with malignant obstruction found that silicone tubes needed replacement about four times as often as polyurethane ones, with replacement rates of roughly 10% versus 3%.⁵ The main reasons were debris obstruction and accidental dislodgement. Silicone tubes of the same labeled size have a narrower internal channel than polyurethane tubes, making them clog more easily. They also relied on a small balloon inside the kidney to stay put, and that balloon was prone to rupturing, which led to the tube slipping out.

Polyurethane tubes, on the other hand, were anchored directly to the skin with sutures, which proved more secure. But polyurethane had its own downside: skin inflammation at the insertion site was far more common, occurring in about 10% of polyurethane cases versus about 3% with silicone.⁵ So the choice is not straightforward: polyurethane generally lasts longer and stays in place better, but it can irritate the skin more. Your doctor’s preference usually depends on how long the tube is expected to stay, how active you are, and how your skin tends to react.

What Happens When Tubes Are Left Too Long

A large retrospective study of 569 nephrostomy procedures documented a 4% rate of major complications, including serious bleeding, blood infections, and lung-related problems like fluid or air around the lung. Minor complications were much more common, at 38%, and included urinary tract infections, tube blockage by debris, urine leaking around the tube, and skin irritation at the exit site. About 14% of tubes slipped out unintentionally, and another 14% of procedures were followed by urinary tract infections.⁶

Tube malfunction can take several forms beyond simple blockage. In one hospital’s experience, complications included the catheter leaking, fracturing, or kinking in addition to the more common obstruction.⁷ A kinked tube may still drain intermittently, which makes it easy to miss until the kidney starts backing up. Any sudden drop in output from the drainage bag, pain in the flank, fever, or cloudy and foul-smelling urine are warning signs that the tube may be malfunctioning and that you should contact your medical team rather than waiting for the next scheduled exchange.

Another less-discussed issue is hypergranulation tissue, a fleshy overgrowth of healing tissue around the tube’s skin exit site. It can bleed easily and become a chronic nuisance for long-term tube patients. Treatment usually involves topical agents to shrink the tissue, though it sometimes recurs.⁸

Pregnancy Requires a Much Shorter Schedule

Pregnant patients who need nephrostomy tubes face a dramatically accelerated timeline for tube exchanges. In one study comparing pregnant and non-pregnant patients, the average exchange interval was about 3.4 weeks for the pregnant group versus 5.7 weeks for the non-pregnant group. Pregnant patients were also far more likely to need an unscheduled emergency exchange before the planned 6-week appointment, with about 80% requiring early reintervention compared to roughly 22% of non-pregnant patients.⁹ Based on these findings, the researchers suggested that a routine 3-week exchange cycle may be necessary during pregnancy.

A separate study of nephrostomy tubes during pregnancy confirmed these challenges. The median dwell time was 31 days, but a significant proportion of tubes had to be exchanged prematurely. Out of 27 insertions and exchanges, 10 were premature, driven by seven blockages and three dislodgements. All seven blocked tubes had calcium encrustation at the tip.¹⁰ Pregnancy changes urinary chemistry in ways that accelerate mineral deposition, which is why the standard 60-to-90-day schedule does not apply. If you are pregnant and have a nephrostomy tube, expect more frequent hospital visits for exchanges than the usual patient.

Quality of Life with a Long-Term Tube

Living with a nephrostomy tube is not easy. A study measuring quality of life, pain, and anxiety in nephrostomy patients found that quality of life worsened significantly by the time of the first tube replacement. Women in the study reported worse outcomes across all three measures, experiencing more pain, more anxiety, and lower overall quality of life than men.¹¹

Much of the daily burden comes from practical issues: managing the drainage bag, keeping the exit site clean, limiting certain physical activities, and dealing with the constant awareness that a tube is protruding from your back. Sleep is often disrupted because rolling onto the wrong side can tug the tube. Showering requires extra care, and swimming or soaking in a bath is generally off the table. Over months or years, these restrictions add up. For patients with cancer-related obstructions who may need the tube for the rest of their lives, the psychological toll is substantial and tends to be underrecognized by healthcare teams focused on the tube’s mechanical function.

Nephrostomy Tubes Versus Internal Stents

For many of the same conditions that call for a nephrostomy tube, an alternative is an internal ureteral stent, a thin tube threaded through the ureter from the inside so nothing exits through the skin. Patients and physicians naturally compare the two, and the evidence suggests each has distinct advantages. A meta-analysis of comparative studies found that internal stents had significantly fewer accidental dislodgements than nephrostomy tubes and were associated with shorter hospital stays and faster procedure times.¹²

But nephrostomy tubes had their own edge. In one study of long-term ureteral obstruction, the nephrostomy group showed less residual swelling of the kidney after decompression and a smaller rise in creatinine, a blood marker for kidney function, compared to the stent group. About 10% of patients who started with internal stents had to be converted to nephrostomy tubes during the study.¹³ A separate study reported an overall success rate of 92% for nephrostomy versus 83% for internal stenting.¹⁴

A prospective quality-of-life study adds an interesting nuance. At first, stent patients complained more about urinary discomfort (frequent urges, burning), while nephrostomy patients struggled more with mobility and personal hygiene because of the external tube. Over time, though, nephrostomy patients adapted and their symptoms improved, while stent patients’ urinary discomfort persisted. By the second assessment point, nephrostomy patients actually reported better overall quality of life than stent patients.¹⁵ The takeaway is that the “better” option depends heavily on how long you expect to need drainage and what aspects of daily life matter most to you.

Protecting Kidney Function Over Time

One of the primary reasons for placing a nephrostomy tube is to relieve pressure on the kidney and preserve its ability to filter blood. When urine cannot drain, pressure builds in the collecting system, and that back-pressure eventually damages the tiny filtering units inside the kidney. How much function recovers after drainage depends on how long and how severely the obstruction has been in place. If caught early enough, the damage can be fully reversible. Left too long, it causes scarring and permanent loss.¹⁶

In children with pelvic tumors causing upper urinary tract obstruction, nephrostomy placement made a meaningful difference. Patients who received nephrostomy tubes showed substantial improvement in kidney filtration rate by the end of their cancer treatment, while those who did not have nephrostomy showed essentially no change.¹⁷ This underscores that the tube is not just a convenience; it can be the difference between saving and losing a kidney, particularly when the underlying condition takes months to treat.

Nephrostomy in Children

Infants and young children present unique challenges for nephrostomy management. The anatomy is smaller, the patient cannot communicate symptoms clearly, and keeping a tube secure on a squirming toddler is inherently harder. Nevertheless, the procedure is considered feasible and effective in pediatric patients, often serving as a temporary bridge while doctors plan definitive corrective surgery for conditions like congenital urinary tract abnormalities.¹⁸ Exchange intervals in children are generally shorter than in adults, partly because the smaller-caliber tubes used are more prone to clogging, and partly because children grow and the tube’s position relative to the kidney can shift. Parents managing a child’s nephrostomy tube at home face a steep learning curve, and pediatric centers typically provide dedicated nursing support for tube care education.

Antimicrobial Coatings and the Future of Tube Design

Given that infection and encrustation are what limit tube lifespan, a lot of research has gone into making tubes that resist both. One promising approach involves coating the catheter surface with a combination of antimicrobial agents. In laboratory testing, catheters coated with a minocycline-rifampin combination plus chlorhexidine completely prevented biofilm formation for up to three weeks against a range of bacteria and fungi, including drug-resistant strains commonly found in nephrostomy-related infections.¹⁹

Another line of research uses silver nanoparticles embedded directly into the catheter material. When distributed evenly through polyurethane or silicone, these particles provide broad antimicrobial activity and also reduce mineral encrustation on the catheter surface.²⁰ Neither technology has replaced standard uncoated tubes in routine clinical practice yet, but they represent the direction the field is heading. If antimicrobial coatings can push the encrustation timeline out significantly, exchange intervals could safely lengthen, reducing the number of procedures patients endure over months and years of tube dependence.

It is worth noting that heparin coatings have also been investigated as a way to prevent biofilm attachment on urinary devices.²¹ The idea is that a slippery, anti-adhesive surface makes it harder for bacteria to latch on in the first place. Results have been mixed, and no single coating strategy has emerged as clearly superior. The ideal urinary tract biomaterial, one that resists both infection and mineral buildup for months at a time, has not been found yet.¹ Until it is, regular exchange appointments remain the cornerstone of safe long-term nephrostomy care.

1
PubMed. Urinary tract biomaterials
2
Materials Chemistry and Physics. Chemical composition of explanted deteriorated nephrostomy polyurethane-catheters through X-ray photoelectron spectroscopy
3
PubMed Central. Long-Term Percutaneous Nephrostomy Management of Malignant Urinary Obstruction: Estimation of Optimal Exchange Frequency and Estimation of the Financial Impact of Patient Compliance
4
Clinical Imaging. Vascular and Interventional Radiology New clinic workflow improves compliance for routine PCN exchanges
5
Romanian Journal of Medical Practice. Comparative Study of Silicone and Polyurethane Nephrostomy Catheters used for long-term Urinary Drainage in Malignancy
6
PubMed. Complications associated with percutaneous nephrostomies. A retrospective study
7
PubMed Central. Complications of percutaneous nephrostomy in a district general hospital
8
PubMed. Policresulen to treat hypergranulation tissue around drainage tubes
9
PubMed. Rethinking Time-to-Exchange: Outcomes of Nephrostomy Tube Placement in Pregnancy
10
PubMed Central. Dwell time of percutaneous nephrostomies in pregnancy – what is the optimal exchange interval?
11
PubMed Central. Quality of life, pain and anxiety in patients with nephrostomy tubes
12
International Braz J Urol. Nephrostomy tube versus double J ureteral stent in patients with malignant ureteric obstruction. A systematic review and meta-analysis of comparative studies
13
Urological Science. Comparison between the use of percutaneous nephrostomy and internal ureteral stenting in the management of long-term ureteral obstructions
14
PubMed Central. Comparison between Double J (DJ) Ureteral Stenting and Percutaneous Nephrostomy (PCN) in Obstructive Uropathy
15
PubMed Central. Ureteric stent versus percutaneous nephrostomy for acute ureteral obstruction – clinical outcome and quality of life: a bi-center prospective study
16
F1000Research. Predictive factor of renal function recoverability in upper-tract obstructive uropathy after percutaneous nephrostomy and Double -J stent insertion in Indonesian National Referral Hospital
17
PubMed Central. Effect of emergent nephrostomy on long-term total and split renal function in patients with upper urinary tract obstruction due to pelvic malignant tumors
18
PubMed Central / Elsevier. Percutaneous nephrostomy placement in infants and young children
19
PubMed Central. In Vitro Study of Antimicrobial Percutaneous Nephrostomy Catheters for Prevention of Renal Infections
20
PubMed. Prevention of catheter-related infections: the potential of a new nano-silver impregnated catheter
21
PubMed. Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy